Skip to main content
Top
Published in: Obesity Surgery 4/2024

28-02-2024 | Probiotics | Original Contributions

Effects of Probiotic Use on Gastrointestinal Symptoms in the Late Postoperative Period of Bariatric Surgery: A Cross-Over, Randomized, Triple-Blind, Placebo-Controlled Study

Authors: Nathalia Ramori Farinha Wagner, Maria Clara Peixoto Lopes, Ricardo Fernandes, Cesar Augusto Taconelli, Giovanna Mozzaquatro Nascimento, Julia Pessini, Erasmo Benicio Santos de Moraes Trindade, Antonio Carlos Ligocki Campos

Published in: Obesity Surgery | Issue 4/2024

Login to get access

Abstract

Introduction

Despite the benefits associated with weight reduction, the anatomical and functional changes of bariatric surgery may favor the development of undesirable side effects such as the appearance of gastrointestinal symptoms (GIS). The aim of this study was to evaluate the effects of using probiotics in individuals with GIS 1 year after being submitted to Roux-en-Y Gastric Bypass (RYGB).

Materials and Methods

This is an experimental, prospective, randomized, cross-over, triple-blind, placebo-controlled study, carried out with patients 1 year after being submitted to RYGB and who reported at least one moderate GIS. Subjects were randomized into two groups and completed the two research periods: in one they received placebo capsules, in the other 50 billion CFU of probiotics (Lactobacillus acidophilus, Bifidobacterium lactis, Lactobacillus rhamnosus, Bifidobacterium longum, Lactobacillus plantarum, Bifidobacterium bifidum and Lactobacillus gasseri), both for 8 weeks, with 8 weeks of wash-out period in between, and were evaluated for the presence of Small Intestine Bacterial Overgrowth (SIBO) and GIS, through the Hydrogen breath test and Gastric Symptom Rating Scale (GSRS) questionnaire.

Results

Of a total of 56 participants, 47 individuals completed the study. No significant effects were observed in neither the gastrointestinal symptoms or in the prevalence of SIBO with the use of probiotics.

Conclusion

Supplementation of the probiotics chosen for this study does not seem to alleviate GIS or influence the improvement of SIBO in symptomatic patients after 1 year of RYGB.

Graphical Abstract

Literature
9.
15.
go back to reference Gutiérrez-Repiso C, Moreno-Indias I, Tinahones FJ. Shifts in gut microbiota and their metabolites induced by bariatric surgery. Impact of factors shaping gut microbiota on bariatric surgery outcomes. Rev Endocr Metab Disord. 2021;22(4):1137–1156. https://doi.org/10.1007/s11154-021-09676-8. Gutiérrez-Repiso C, Moreno-Indias I, Tinahones FJ. Shifts in gut microbiota and their metabolites induced by bariatric surgery. Impact of factors shaping gut microbiota on bariatric surgery outcomes. Rev Endocr Metab Disord. 2021;22(4):1137–1156. https://​doi.​org/​10.​1007/​s11154-021-09676-8.
16.
go back to reference Waitzberg DL, Quilici FA, Michzputen S, Friche Passos M. do C. The effect of probiotic fermented milk that includes Bifidobacterium lactis cncm i-2494 on the reduction of gastrointestinal discomfort and symptoms in adults: a narrative review. Nutr Hosp. 2015;32(2):501–9. https://doi.org/10.3305/nh.2015.32.2.9232. Waitzberg DL, Quilici FA, Michzputen S, Friche Passos M. do C. The effect of probiotic fermented milk that includes Bifidobacterium lactis cncm i-2494 on the reduction of gastrointestinal discomfort and symptoms in adults: a narrative review. Nutr Hosp. 2015;32(2):501–9. https://​doi.​org/​10.​3305/​nh.​2015.​32.​2.​9232.
23.
go back to reference Yormaz S, Yilmaz K, Alptekin H, Ece I, Acar F, Colak B, et al. Does digestive symptoms require esophago gastroscopy prior to bariatric procedure? Assessment of 6 years’ experience. Ann Ital Chir. 2018;89:36–44.PubMed Yormaz S, Yilmaz K, Alptekin H, Ece I, Acar F, Colak B, et al. Does digestive symptoms require esophago gastroscopy prior to bariatric procedure? Assessment of 6 years’ experience. Ann Ital Chir. 2018;89:36–44.PubMed
27.
28.
go back to reference Gomi A, Yamaji K, Watanabe O, Yoshioka M, Miyazaki K, Iwama Y, et al. Bifidobacterium bifidum YIT 10347 fermented milk exerts beneficial effects on gastrointestinal discomfort and symptoms in healthy adults: a double-blind, randomized, placebo-controlled study. J Dairy Sci. 2018;101(6):4830–41. https://doi.org/10.3168/jds.2017-13803.CrossRefPubMed Gomi A, Yamaji K, Watanabe O, Yoshioka M, Miyazaki K, Iwama Y, et al. Bifidobacterium bifidum YIT 10347 fermented milk exerts beneficial effects on gastrointestinal discomfort and symptoms in healthy adults: a double-blind, randomized, placebo-controlled study. J Dairy Sci. 2018;101(6):4830–41. https://​doi.​org/​10.​3168/​jds.​2017-13803.CrossRefPubMed
29.
go back to reference Francavilla R, Piccolo M, Francavilla A, Polimeno L, Semeraro F, Cristofori F, et al. Clinical and microbiological effect of a multispecies probiotic supplementation in celiac patients with persistent IBS-type symptoms: a randomized, double-blind, placebo-controlled. Multicenter Trial J Clin Gastroenterol. 2019;53(3):e117–25. https://doi.org/10.1097/MCG.0000000000001023.CrossRefPubMed Francavilla R, Piccolo M, Francavilla A, Polimeno L, Semeraro F, Cristofori F, et al. Clinical and microbiological effect of a multispecies probiotic supplementation in celiac patients with persistent IBS-type symptoms: a randomized, double-blind, placebo-controlled. Multicenter Trial J Clin Gastroenterol. 2019;53(3):e117–25. https://​doi.​org/​10.​1097/​MCG.​0000000000001023​.CrossRefPubMed
31.
go back to reference Hata S, Nakajima H, Hashimoto Y, Miyoshi T, Hosomi Y, Okamura T, et al. Effects of probiotic Bifidobacterium bifidum G9–1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open-label, single-arm, exploratory research trial. J Diabetes Investig. 2022;13(3):489–500. https://doi.org/10.1111/jdi.13698. Hata S, Nakajima H, Hashimoto Y, Miyoshi T, Hosomi Y, Okamura T, et al. Effects of probiotic Bifidobacterium bifidum G9–1 on the gastrointestinal symptoms of patients with type 2 diabetes mellitus treated with metformin: An open-label, single-arm, exploratory research trial. J Diabetes Investig. 2022;13(3):489–500. https://​doi.​org/​10.​1111/​jdi.​13698.
36.
go back to reference Gasbarrini A, Corazza GR, Gasbarrini G, Montalto M, Di Stefano M, Basilisco G, et al. 1st Rome H2-Breath Testing Consensus Conference Working Group. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther. 2009;29 Suppl 1:1–49. https://doi.org/10.1111/j.1365-2036.2009.03951.x. Erratum in: Aliment Pharmacol Ther. 2010 Jan;31(1):166. Satta PU [corrected to Usai-Satta P]. Gasbarrini A, Corazza GR, Gasbarrini G, Montalto M, Di Stefano M, Basilisco G, et al. 1st Rome H2-Breath Testing Consensus Conference Working Group. Methodology and indications of H2-breath testing in gastrointestinal diseases: the Rome Consensus Conference. Aliment Pharmacol Ther. 2009;29 Suppl 1:1–49. https://​doi.​org/​10.​1111/​j.​1365-2036.​2009.​03951.​x. Erratum in: Aliment Pharmacol Ther. 2010 Jan;31(1):166. Satta PU [corrected to Usai-Satta P].
37.
Metadata
Title
Effects of Probiotic Use on Gastrointestinal Symptoms in the Late Postoperative Period of Bariatric Surgery: A Cross-Over, Randomized, Triple-Blind, Placebo-Controlled Study
Authors
Nathalia Ramori Farinha Wagner
Maria Clara Peixoto Lopes
Ricardo Fernandes
Cesar Augusto Taconelli
Giovanna Mozzaquatro Nascimento
Julia Pessini
Erasmo Benicio Santos de Moraes Trindade
Antonio Carlos Ligocki Campos
Publication date
28-02-2024
Publisher
Springer US
Published in
Obesity Surgery / Issue 4/2024
Print ISSN: 0960-8923
Electronic ISSN: 1708-0428
DOI
https://doi.org/10.1007/s11695-024-07117-4

Other articles of this Issue 4/2024

Obesity Surgery 4/2024 Go to the issue